Cargando…
Economic evaluations and their use in infection prevention and control: a narrative review
BACKGROUND: The objective of this review is to provide a comprehensive overview of the different types of economic evaluations that can be utilized by Infection Prevention and Control practitioners with a particular focus on the use of the quality adjusted life year, and its associated challenges. W...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5828323/ https://www.ncbi.nlm.nih.gov/pubmed/29492261 http://dx.doi.org/10.1186/s13756-018-0327-z |
_version_ | 1783302618572914688 |
---|---|
author | Rennert-May, Elissa Conly, John Leal, Jenine Smith, Stephanie Manns, Braden |
author_facet | Rennert-May, Elissa Conly, John Leal, Jenine Smith, Stephanie Manns, Braden |
author_sort | Rennert-May, Elissa |
collection | PubMed |
description | BACKGROUND: The objective of this review is to provide a comprehensive overview of the different types of economic evaluations that can be utilized by Infection Prevention and Control practitioners with a particular focus on the use of the quality adjusted life year, and its associated challenges. We also highlight existing economic evaluations published within Infection Prevention and Control, research gaps and future directions. DESIGN: Narrative Review. CONCLUSIONS: To date the majority of economic evaluations within Infection Prevention and Control are considered partial economic evaluations. Acknowledging the challenges, which include variable utilities within infection prevention and control, a lack of randomized controlled trials, and difficulty in modelling infectious diseases in general, future economic evaluation studies should strive to be consistent with published guidelines for economic evaluations. This includes the use of quality adjusted life years. Further research is required to estimate utility scores of relevance within Infection Prevention and Control. |
format | Online Article Text |
id | pubmed-5828323 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-58283232018-02-28 Economic evaluations and their use in infection prevention and control: a narrative review Rennert-May, Elissa Conly, John Leal, Jenine Smith, Stephanie Manns, Braden Antimicrob Resist Infect Control Review BACKGROUND: The objective of this review is to provide a comprehensive overview of the different types of economic evaluations that can be utilized by Infection Prevention and Control practitioners with a particular focus on the use of the quality adjusted life year, and its associated challenges. We also highlight existing economic evaluations published within Infection Prevention and Control, research gaps and future directions. DESIGN: Narrative Review. CONCLUSIONS: To date the majority of economic evaluations within Infection Prevention and Control are considered partial economic evaluations. Acknowledging the challenges, which include variable utilities within infection prevention and control, a lack of randomized controlled trials, and difficulty in modelling infectious diseases in general, future economic evaluation studies should strive to be consistent with published guidelines for economic evaluations. This includes the use of quality adjusted life years. Further research is required to estimate utility scores of relevance within Infection Prevention and Control. BioMed Central 2018-02-27 /pmc/articles/PMC5828323/ /pubmed/29492261 http://dx.doi.org/10.1186/s13756-018-0327-z Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Review Rennert-May, Elissa Conly, John Leal, Jenine Smith, Stephanie Manns, Braden Economic evaluations and their use in infection prevention and control: a narrative review |
title | Economic evaluations and their use in infection prevention and control: a narrative review |
title_full | Economic evaluations and their use in infection prevention and control: a narrative review |
title_fullStr | Economic evaluations and their use in infection prevention and control: a narrative review |
title_full_unstemmed | Economic evaluations and their use in infection prevention and control: a narrative review |
title_short | Economic evaluations and their use in infection prevention and control: a narrative review |
title_sort | economic evaluations and their use in infection prevention and control: a narrative review |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5828323/ https://www.ncbi.nlm.nih.gov/pubmed/29492261 http://dx.doi.org/10.1186/s13756-018-0327-z |
work_keys_str_mv | AT rennertmayelissa economicevaluationsandtheiruseininfectionpreventionandcontrolanarrativereview AT conlyjohn economicevaluationsandtheiruseininfectionpreventionandcontrolanarrativereview AT lealjenine economicevaluationsandtheiruseininfectionpreventionandcontrolanarrativereview AT smithstephanie economicevaluationsandtheiruseininfectionpreventionandcontrolanarrativereview AT mannsbraden economicevaluationsandtheiruseininfectionpreventionandcontrolanarrativereview |